Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Statins Would Have Special Status Under Health Savings Accounts

Executive Summary

Statins will qualify as preventive care under revised Treasury Department guidelines for health savings accounts, sheltering consumers from prices for the drugs

You may also be interested in...



CMS Considering Obesity Drug Coverage Under Medicare Rx Benefit

The Centers for Medicare & Medicaid Services is seeking comment on how obesity treatments can be covered under the Medicare Rx benefit despite language in the law that prohibits coverage of "weight loss" drugs

CMS Considering Obesity Drug Coverage Under Medicare Rx Benefit

The Centers for Medicare & Medicaid Services is seeking comment on how obesity treatments can be covered under the Medicare Rx benefit despite language in the law that prohibits coverage of "weight loss" drugs

Merck/Schering Vytorin Launch Could Be Aided By New Cholesterol Guidelines

Revised cholesterol treatment guidelines could result in increased use of combination lipid-lowering therapies as Merck/Schering-Plough's Vytorin enters the market

Related Content

Topics

UsernamePublicRestriction

Register

PS044445

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel